ALUR.US Allurion Technologies, Inc.

Healthcare Diversified Consumer Services USA Stocks
0.0020 USD
Close of Nov 13, 2026
0.0009 8.52
Market cap
USD 1.22K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is ALUR.US undervalued?

Graham number

The Graham number of Allurion Technologies, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Allurion Technologies, Inc. fundamental analysis

No fundamental analysis for Allurion Technologies, Inc. yet.

Allurion Technologies, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Allurion Technologies, Inc.

Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Mass…

Full company profile